ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
28 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma Share Discussion Threads

Showing 17601 to 17619 of 39350 messages
Chat Pages: Latest  710  709  708  707  706  705  704  703  702  701  700  699  Older
DateSubjectAuthorDiscuss
28/1/2021
08:27
Big sell offs in the markets, what was the trigger?
katsy
28/1/2021
08:24
Back to £1.25+ in following days IMO

Buy fear.

under the radars
28/1/2021
08:22
Back below 100p in coming days IMO
daar
28/1/2021
08:12
So we are looking at £10 by Q1 according to the guru here??Guys don't sell now you have 1000% upside in 60 days.Apparently its a no brainer.You have to laugh at the mentality of some.
bluebear1
27/1/2021
22:59
Thanks Bermudashorts, I had not seen this article before. Microbiome seriously on the map and interest growing all the time is my impression
thresholdbypass
27/1/2021
22:09
I have no idea whether this has already been posted but the article below explains in layman's terms some amazing research from Brigham and Women’s Hospital (Harvard).

They've discovered that a certain type of brain cell can protect the brain from inflammation and that the anti-inflammatory activity of these cells is controlled by the microbiome.

'“Finding microbiome-controlled anti-inflammatory subsets of astrocytes is an important advance in our understanding of CNS inflammation and its regulation,” says Quintana. “This is a very novel mechanism by which the gut controls inflammation in the brain. It guides new therapies for neurological diseases, and we believe that this mechanism could contribute to the pathogenesis of brain tumors.”'

bermudashorts
27/1/2021
21:20
surely that is transparent ?
swallowsflysouth
27/1/2021
21:15
I think it would have been more honest if the article had read 'its more effective to get the virus and hopefully recover'.
goodgrief
27/1/2021
21:08
Goodgrief, tell me something that guarantees 'complete' recovery or any other kind of recover.
swallowsflysouth
27/1/2021
21:04
... recovery isn't guaranteed.
goodgrief
27/1/2021
20:06
Been here for over a year
the stigologist
27/1/2021
18:47
I thought exactly the same but I think it references the immediate cash that comes with the takeover. However, I wouldn't be shocked to see a raft of news shortly after the Nasdaq listing and a raise soon after, hopefully to coincide with a decent rise in the share price to minimise dilution. The fund raise would be solely on the Nasdaq to provide liquidity which will also be needed to sustain a decent rise. That is just my humble opinion and how I see things spanning out, I am sure others have different views and I respect them. Nai, Dyor, wtfdik.
devonlad
27/1/2021
18:45
Kiddies getting impatient :)
wigwammer
27/1/2021
18:17
Post 033

What does anyone think is implied by the use of the word, 'immediate'?

"while providing immediate access to additional funds to support our pipeline"

ptolemy
27/1/2021
16:15
Not expecting any news from conference.Actually don't want it. Would have to update SEC filing holding up Nasdaq listing.
vanduke
27/1/2021
16:14
Oh so eloquent Stig, if only the politicians could express themselves in such a way
churchwins
27/1/2021
15:52
22-10-20 rns

Despite the tremendous operational and economic challenges in 2020 created by the global pandemic, 4D has made significant strides on a number of fronts. This includes 4D presenting clinical data for Live Biotherapeutics for the treatment of cancer in combination with MSD's Keytruda®, as well as positive Phase II results for the first drug candidate able to treat both IBS-C and IBS-D. In addition, earlier in 2020 4D was able to quickly instigate a Phase II clinical trial in COVID-19 based on our detailed understanding of our asthma program," commented Duncan Peyton, Chief Executive Officer of 4D. "We expect that a NASDAQ Listing will allow 4D to capitalise on increased interest from US healthcare investors in recent years and provide access to a much larger pool of specialist capital, thereby increasing our global profile and exposure. NASDAQ is an attractive market for growing, innovative biotech companies. The Merger will accelerate and de-risk 4D's admission to NASDAQ, while providing immediate access to additional funds to support our pipeline."

under the radars
27/1/2021
15:18
All markets down today anyway by the way
thresholdbypass
27/1/2021
15:17
Or buy more if you can...
thresholdbypass
Chat Pages: Latest  710  709  708  707  706  705  704  703  702  701  700  699  Older